Daptomycin Labatec 350 mg

Daptomycin Labatec 350 mg is a medicine authorised by Swissmedic under authorisation number 66651. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 January 2019 and the authorisation is valid without a time limit. ATC code J01XX09 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 66651
  • ATC J01XX09
  • Synthetic medicines
Authorisation data
Authorisation number66651
NameDaptomycin Labatec 350 mg
Full nameDaptomycin Labatec 350 mg, poudre pour solution injectable ou pour perfusion
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01XX09
First authorisation23 January 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Daptomycin Labatec 350 mg, poudre pour solution injectable ou pour perfusionA23 January 2019
2Daptomycin Labatec 500 mg, poudre pour solution injectable ou pour perfusionA23 January 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J01XX0908.01.9.A
35Durchstechflasche(n)J01XX0908.01.9.A
21Durchstechflasche(n)J01XX0908.01.9.A
45Durchstechflasche(n)J01XX0908.01.9.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Daptomycin Labatec 350 mg authorised in Switzerland?

Yes. Daptomycin Labatec 350 mg is authorised by Swissmedic under authorisation number 66651, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Daptomycin Labatec 350 mg have?

Daptomycin Labatec 350 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Daptomycin Labatec 350 mg?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com